Report Description

The stem cell market is growing rapidly due to increasing regulatory approval. The benefits of the stem cell therapy are also attracting an increasing number of patients. Intensive R&D efforts and the increasing research investments on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. The product submarkets for human and embryo stem cells are also expected to drive the growth of the overall stem cells market. However, the high cost of the therapy may affect market growth. This report will help stakeholders gain a better understanding of product pricing and regulatory framework governing market dynamics. The U.S. currently forms the most lucrative stem cells market, especially for areas such as stem cell bone marrow transplantation.

Scope of the report

The report categorizes the global stem cell market as follows:

• Products (adult stem cell, human embryonic stem cell, and other stem cell types)
• Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )
• Technology (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)
• Applications (regenerative medicine – neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

What makes our reports unique?

1. We provide the longest market segmentation chain in the industry with our three-level market breakdown and our analysis of minimum 40 collectively exhaustive and mutually exclusive micro markets.
2. We provide 10% customization to ensure that our clients find the specific market intelligence they need.
3. Each report is about 150 pages, featuring 30+ market data tables, 30+ company profiles, and an analysis of 200 patents.
4. No single report by any other publisher provides market data for all market segments (i.e. products, services, applications, ingredients, and technology) covering the four geographies of North America, Europe, Asia Pacific, and ROW.
5. 15 pages of high level analysis identifying opportunities, best practices, entry strategies, benchmarking strategies, market positioning, product positioning, and competitive positioning.

Key questions answered

1. Which are the high-growth segments and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
2. What are market estimates and forecasts; which markets are doing well and which are not?
3. Where are the gaps and opportunities; what factors are driving market growth?
4. Which are the key playing fields and winning-edge imperatives?
5. What is the competitive landscape; who are the main players in each segment; what are their strategic directives, operational strengths, key selling products, and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies.

1 INTRODUCTION
  1.1 Key take-aways
  1.2 Report description
  1.3 Research methodology
  1.4 Stakeholders

2 SUMMARY

3 MARKET OVERVIEW
  3.1 Defining the stem cell market
  3.2 Factors influencing the stem cells market
  3.3 Stem cell market inhibitors
  3.4 Regenerative medicine dominates stem cell applications
  3.5 Factors influencing the stem cells market
      3.5.1 U.S. lifts ban on funding
      3.5.2 Guidelines for responsible stem cells research
      3.5.3 European national policies and legal issues
      3.5.4 E.U. funding for stem cells research
      3.5.5 Asia Pacific
  3.6 Stem cell patent analysis 

4 STEM CELL MARKET DYNAMICS
  4.1 Drivers
      4.1.1 Potential of stem cells in regenerative medicine
      4.1.2 Key to anti-ageing and prolonging life
      4.1.3 Increasing R&D investments in adult stem cell research
      4.1.4 Ease of administration
      4.1.5 Reduced risk of tissue rejection in transplants
      4.1.6 Federal funding for stem cell research
  4.2 Restraints
      4.2.1 Safety issues
      4.2.2 Ethical issues
      4.2.3 Insurance issues 
  4.3 Opportunities
      4.3.1 Technological innovations
      4.3.2 Emerging application as a drug discovery tool
      4.3.3 Other promising applications

5 GLOBAL STEM CELLS PRODUCT MARKET
  5.1 Potency-based stem cell classification
  5.2 Adult stem cells
      5.2.1 Drivers
            5.2.1.1 Applications in cancer and chronic disease treatment
            5.2.1.2 Availability of adequate safety & efficacy evidence
            5.2.1.3 Technology innovations
            5.2.1.4 Lower costs & no ethical issues
      5.2.2 Restraints & opportunities
            5.2.2.1 Lower therapeutic potential
            5.2.2.2 Need for minimising intervention
      5.2.3 Hematopoietic stem cells
            5.2.3.1 Drivers & restraints
                    5.2.3.1.1 Wide range of applications
                    5.2.3.1.2 Technology developments
                    5.2.3.1.3 Underused treatment, ineffective GVHD management
      5.2.4 Mesenchymal stem cells
            5.2.4.1 Drivers
                    5.2.4.1.1 Huge potential of MSCS
                    5.2.4.1.2 Advantageous cell type for allogenic transplantation
            5.2.4.2 Restraints & opportunities
                    5.2.4.2.1 Low number of mesenchymal stem cells in bone marrow
            5.2.4.3 Potential applications of MSC therapy
  5.3 Embryonic stem cells
      5.3.1 Drivers & restraints
            5.3.1.1 Immense potential due to pluripotent nature
            5.3.1.2 Ban on federal funding lifted
            5.3.1.3 Ethical issues and inadequate safety data
      5.3.2 Umbilical cord stem cells
      5.3.3 Neuronal stem cells
      5.3.4 Dental stem cells
      5.3.5 Other novel cell types
 
6 STEM CELLS TECHNOLOGY MARKET
  6.1 Stem cell production
      6.1.1 Somatic nuclear transfer / therapeutic cloning
      6.1.2 IVF (in vitro fertilization)
      6.1.3 Isolation & cell culture
  6.2 Expansion & sub-culture
  6.3 Stem cell acquisition
      6.3.1 Bone marrow harvest
      6.3.2 Apheresis
      6.3.3 Umbilical cord blood stem cells acquisition
  6.4 Cryopreservation & storage

7 GLOBAL STEM CELLS SERVICES MARKET
  7.1 Stem cell banking
      7.1.1 Ethical issues on stem cell banking
  7.2 Stem cell acquisition & testing
  7.3 Characterization services
      7.3.1 HLA typing services
      7.3.2 Stem cell custom services
      7.3.3 Stem cell custom antibody services
  7.4 Molecular biology
  7.5 Drug screening & target validation

8 GLOBAL STEM CELLS APPLICATIONS MARKET
  8.1 Regenerative medicine
      8.1.1 Drivers & restraints
            8.1.1.1 Simple and cost-effective production method 
            8.1.1.2 Public & political support
            8.1.1.3 High cost of treatment and low reimbursements
      8.1.2 Neurological disorders
            8.1.2.1 Alzheimer’s disease
            8.1.2.2 Parkinson’s disease
            8.1.2.3 Multiple sclerosis
            8.1.2.4 Other diseases
      8.1.3 Myocardial infarction & cardiovascular diseases
      8.1.4 Cancer
            8.1.4.1 Breast cancer
            8.1.4.2 Multiple myeloma
            8.1.4.3 Other cancers
      8.1.5 Injuries
      8.1.6 Incontinence
      8.1.7 Diabetes
      8.1.8 Orthopedics
      8.1.9 Liver disorders
      8.1.10 Hematological disorders
             8.1.10.1 Other applications
                      8.1.10.1.1 Limb ischemia
                      8.1.10.1.2 Systemic lupus
  8.2 Drug discovery & development
 
9 GEOGRAPHIC ANALYSIS
  9.1 North America
  9.2 Europe
  9.3 Asia
  9.4 RoW
 
10 COMPETITIVE LANDSCAPE

11 COMPANY PROFILES
   11.1 ADVANCED CELL TECHNOLOGY INC
   11.2 ALDAGEN
   11.3 ANGEL BIOTECHNOLOGY
   11.4 ANGIOBLAST SYSTEMS INC
   11.5 AASTROM BIOSCIENCES
   11.6 ATHERSYS
   11.7 BIOHEART
   11.8 BRAINSTORM CELL THERAPEUTICS
   11.9 CALIFORNIA STEM CELL
   11.10 CELGENE CORPORATION
   11.11 CELLARTIS AB
   11.12 CELLERANT THERAPEUTICS
   11.13 CELLULAR DYNAMICS INTERNATIONAL
   11.14 CELLULAR ENGINEERING TECHNOLOGIES
   11.15 CORDLIFE
   11.16 CYTORI THERAPEUTICS
   11.17 ES CELL INTERNATIONAL
   11.18 GAMIDA CELL
   11.19 GENZYME CORPORATION
   11.20 GERON CORPORATION
   11.21 GLOBAL STEM
   11.22 INTERCYTEX
   11.23 MEDISTEM
   11.24 MESOBLAST
   11.25 MULTICELL TECHNOLOGIES
   11.26 NEOSTEM
   11.27 NOVOCELL
   11.28 NEURALSTEM BIOPHARMACEUTICALS
   11.29 OPEXA THERAPEUTICS
   11.30 OSIRIS THERAPEUTICS
   11.31 PLUREON
   11.32 PLURISTEM THERAPEUTICS
   11.33 RENEURON
   11.34 STEMCELLS
   11.35 STEMLIFELINE
   11.36 T2CURE GMBH
   11.37 THERAVITAE
   11.38 THERMO FISHER SCIENTIFIC
   11.39 THERMOGENESIS CORPORATION
   11.40 VETCELL BIOSCIENCE
 
12 APPENDIX
E.U. guidelines for human embryonic stem cell research 
U.S. government policies & guidelines for stem cell research 
Bush’s stem cell policy 
Amendment in the omnibus appropriations act 
The dickey amendment 
NIH guidelines for eligibility of human embryonic 
stem cells for use in research 
Eligibility of human embryonic stem cells derived 
from human embryos: 
Other non-allowable research 
Patents for United States 
Patents for Europe 
Patents for Japan
  
LIST OF TABLES 
 
Summary table global stem cell market by products, services and technology 2009-2014 ($Millions) 
1 Global stem cell market, by products 2007-2014 ($Millions)
2 Global adult stem cell market, by products 2007-2014 ($Millions)
3 Global other novel cell types market, by products 2007-2014 ($Millions)
4 Global stem cell technology market 2007-2014 ($Millions)
5 Global stem cell production market, by products 2007-2014 ($Millions)
6 Global stem cell acquisition market, by products 2007-2014 ($Millions)
7  Global stem cell services market, 2007-2014 ($Millions)
8 Global characterization services market, 2007-2014 ($Millions)
9 Global stem cell applications market, by products 2007-2014 ($Millions)
10  Global stem cell applications market, by geography 2007-2014 ($Millions) 
11  Global regenerative medicine market, by products 2007-2014 ($Millions)
12  Global regenerative medicine market, by geography 2007-2014 ($Millions) 
13  Global neurological disorders market, by geography 2007-2014 ($Millions) 
14  Global myocardial infarction and cardiovascular diseases market, by geography 2007-2014 ($Millions)
15  Global stem cell therapy market for cancer, by geography 2007-2014 ($Millions)
16  Global stem cell therapy market for injuries, by products 2007-2014 ($Millions)
17  Global stem cell therapy market for injuries, by geography 2007-2014 ($Millions)
18  Global stem cell therapy market for incontinence, by geography 2007-2014 ($Millions)
19  Global stem cell therapy market for diabetes, by geography 2007-2014 ($Millions)
20  Global stem cell therapy market for orthopedics, by geography 2007-2014 ($Millions)
21  Global stem cell therapy market for liver disorders, by geography 2007-2014 ($Millions)
22  Global stem cell therapy market for hematological disorders, by geography 2007-2014 ($Millions)
23  Global other regenerative medicines market, by geography 2007-2014 ($Millions)
24  Global drug discovery & development market, by geography 2007-2014 ($Millions)
25  New product, technology, service launch in the stem cells market (2008-2009)
26  Agreements and collaborations in the stem cells market (2008-2009)
27  Mergers and acquisition in the stem cells market (2008-2009)
 
LIST OF FIGURES 
1 Stem cell market segmentation
2 Factors driving stem cell market growth
3 Factors inhibiting stem cell market growth
4 Stem cell application market dynamics
5 Relative importance of factors affecting stem cell market
6 NIH funding for stem cell research
7 Patent analysis by geography 2006 to 2008
8 Patent analysis by segment 2006 to 2008
9 Patent analysis by competitors
10 Major market growth factors
11 Stem cell classification on the basis of potency
12 Stem cell technologies
13 Prominent focus areas in regenerative medicine
14 Stem cell transplants types
15 Global stem cells market by geography ($Billion)
16 North American stem cells market
17 European stem cells market
18 Asian stem cells market
19 RoW stem cells market
20 Major segments in the global stem cell market (2008-2009)
21 Collaborations in the global stem cell market (2008-2009)

Global Stem Cell and Advanced Technologies Market

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Estimated size of stem cell market in 2009